Literature DB >> 6998799

Amniotic fluid C-peptide in normal and insulin-dependent diabetic pregnancies.

G Tchobroutsky, I Heard, C Tchobroutsky, E Eschwege.   

Abstract

Glucose, insulin and C-peptide were determined in amniotic fluid from 28 normal and 46 insulin-treated diabetic pregnant women. Glucose, insulin and C-peptide concentrations in amniotic fluid were higher in the diabetics than in the normal subjects. In diabetic women insulin levels did not correlate with birth weight or birth weight adjusted for gestational age, but C-peptide did. C-peptide correlated poorly with insulin (p < 0.05) in diabetics but closely (p < 0.002) in normal subjects. These results suggest that amniotic fluid investigations in insulin-treated diabetic women should use C-peptide assays as these seem to reflect more closely the insulin production of the fetus than do insulin assays. There were no differences in amniotic fluid glucose, insulin and C-peptide concentrations where the amniotic fluid lecithin-sphingomyelin ratio indicated fetal pulmonary maturity or immaturity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998799     DOI: 10.1007/bf00251007

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  The glucose-insulin ratio in amniotic fluid.

Authors:  R Newman; G Tutera
Journal:  Obstet Gynecol       Date:  1976-05       Impact factor: 7.661

2.  Carbohydrate metabolism in pregnancy. XV. Plasma C-peptide during intravenous glucose tolerance in neonates from normal and insulin-treated diabetic mothers.

Authors:  R L Phelps; N Freinkel; A H Rubenstein; H Kuzuya; B E Metzger; J J Boehm; L Mølsted-Pedersen
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

3.  C-peptide immunoreactivity (CPR): a new method for studying infants of insulin-treated diabetic mothers.

Authors:  M B Block; R S Pildes; N A Mossabhoy; D F Steiner; A H Rubenstein
Journal:  Pediatrics       Date:  1974-06       Impact factor: 7.124

4.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

5.  Maternal, fetal and amniotic fluid levels of glucose, insulin and growth hormone.

Authors:  W N Spellacy; W C Buhi; B Bradley; K K Holsinger
Journal:  Obstet Gynecol       Date:  1973-03       Impact factor: 7.661

6.  C-peptide immunoreactivity (CPR) in urine.

Authors:  T Kuzuya; A Matsuda; Y Sakamoto; S Tanabshi; H Kajinuma
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

7.  [Insulin, C peptide and glucagon in amniotic fluid in normal and diabetic pregnancy].

Authors:  D Andreani; F Fallucca; A Russo; A Maldonato; C Caccamo; G Lamalfa; F de Gado; A Pachi
Journal:  Journ Annu Diabetol Hotel Dieu       Date:  1979

8.  Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.

Authors:  T Kuzuya; T Saito; S Yoshida; A Matsuda
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122

9.  Insulin levels in amniotic fluid. Management of pregnancy in diabetes.

Authors:  P A Weiss; W Lichtenegger; R Winter; P Pürstner
Journal:  Obstet Gynecol       Date:  1978-04       Impact factor: 7.661

10.  Metabolism of proinsulin, insulin, and C-peptide in the rat.

Authors:  A I Katz; A H Rubenstein
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more
  2 in total

1.  Fetal hypoinsulinism as a cause of small infants of smoking mothers?

Authors:  E Eschwege; L Papoz; G Rosselin; C Tchobroutsky
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

Review 2.  Blood glucose levels in diabetic and non-diabetic subjects.

Authors:  G Tchobroutsky
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.